ConductScience.org, home

Paper8014455

Response to interferon alpha therapy is influenced by the iron content of the liver.

Van Thiel DH and 5 others. J Hepatol, 1994. Cited by 230 papers, by iCite.

Cite this record

ConductScience Library. Response to interferon alpha therapy is influenced by the iron content of the liver. Papers, record 8014455. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8014455

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Response to interferon alpha therapy is influenced by the iron content of the liver.
PubMed
Journal
J Hepatol
PubMed
Year
1994
PubMed
Publication types
Clinical Trial, Journal Article
PubMed
Citations, by iCite
230
iCite
Relative citation ratio, by iCite
7.77
iCite
Revised in PubMed
2022-04-19
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Van Thiel DHD H
2Friedlander LL
3Fagiuoli SS
4Wright HIH I
5Irish WW
6Gavaler JSJ S

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hepatitis BMajor topic
Interferon-alphaMajor topic
IronMajor topic
LiverMajor topic
Adult
Alanine Transaminase
Biopsy
Female
Humans
Male
Middle Aged

Source PubMed

Download CSV of topics

Cited by42

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 230 citations.

PMIDTitleJournalYearIn PapersSource
38169881Liver iron overload and fat content analyzed by magnetic resonance contribute to evaluatingthe progression of chronic hepatitis B.Biomed Rep2024https://conductscience.org/library/papers/38169881PubMed
35126838Hepatitis C virus: A critical approach to who really needs treatment.World J Hepatol2022https://conductscience.org/library/papers/35126838PubMed
32015868Treatment of Chronic HCV Infection in Patients With Thalassemia.Clin Liver Dis (Hoboken)2019https://conductscience.org/library/papers/32015868PubMed
29384977Improvement of chronic hepatitis B by iron chelation therapy in a patient with iron overload: A case report.Medicine (Baltimore)2017https://conductscience.org/library/papers/29384977PubMed
27041937Iron, HCV and the liver.World J Gastroenterol1997https://conductscience.org/library/papers/27041937PubMed
25755436Hemochromatosis gene mutations: prevalence and effects on pegylated-interferon and ribavirin therapy response in chronic hepatitis C in sardinia.J Clin Exp Hepatol2012https://conductscience.org/library/papers/25755436PubMed
21845061Effect of hepatic iron concentration and viral factors in chronic hepatitis C-infected patients with thalassemia major, treated with interferon and ribavirin.Int J Gen Med2011https://conductscience.org/library/papers/21845061PubMed
20927485Identification of treatment efficacy-related host factors in chronic hepatitis C by ProteinChip serum analysis.Mol Med2011https://conductscience.org/library/papers/20927485PubMed
20011735The role of iron in the pathophysiology and treatment of chronic hepatitis C.Can J Gastroenterol2009https://conductscience.org/library/papers/20011735PubMed
19777608Iron increases HMOX1 and decreases hepatitis C viral expression in HCV-expressing cells.World J Gastroenterol2009https://conductscience.org/library/papers/19777608PubMed
19669262The effect of iron depletion on chronic hepatitis C virus infection.Hepatol Int2008https://conductscience.org/library/papers/19669262PubMed
19418586Hyperferritinemia is a risk factor for steatosis in chronic liver disease.World J Gastroenterol2009https://conductscience.org/library/papers/19418586PubMed
17846887Phlebotomy improves therapeutic response to interferon in patients with chronic hepatitis C: a meta-analysis of six prospective randomized controlled trials.Dig Dis Sci2008https://conductscience.org/library/papers/17846887PubMed
17729391Iron overload and cofactors with special reference to alcohol, hepatitis C virus infection and steatosis/insulin resistance.World J Gastroenterol2007https://conductscience.org/library/papers/17729391PubMed
17729389HFE gene in primary and secondary hepatic iron overload.World J Gastroenterol2007https://conductscience.org/library/papers/17729389PubMed
16451091Psychiatric and substance use disorders in individuals with hepatitis C: epidemiology and management.Drugs2006https://conductscience.org/library/papers/16451091PubMed
16094713Blood micronutrient, oxidative stress, and viral load in patients with chronic hepatitis C.World J Gastroenterol2005https://conductscience.org/library/papers/16094713PubMed
15307893Synergic effect of chronic hepatitis C infection and beta thalassemia major with marked hepatic iron overload on liver fibrosis: a retrospective cross-sectional study.BMC Gastroenterol2004https://conductscience.org/library/papers/15307893PubMed
14557859Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype.J Mol Med (Berl)2003https://conductscience.org/library/papers/14557859PubMed
12679924Is laparoscopy an advantage in the diagnosis of cirrhosis in chronic hepatitis C virus infection?World J Gastroenterol2003https://conductscience.org/library/papers/12679924PubMed

See all 42 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8014455

GET https://conductscience.org/api/papers/v1/8014455/cited_by?page=2